Tectonic Advisors LLC Gilead Sciences, Inc. Transaction History

Tectonic Advisors LLC

$1.29 Billion
Q1 2024

A detailed history of Tectonic Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tectonic Advisors LLC holds 55,651 shares of GILD stock, worth $3.76 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

55,651

Previous 49,865 11.6%

Holding current value

$3.76 Million

Previous $4.04 Million 0.92%

% of portfolio

0.31%

Previous 0.34%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $414,161 - $505,059	5,786 Added 11.6%	55,651 $4.08 Million
Q4 2023 Jan 17, 2024	BUY	$73.27 - $83.09 $212,702 - $241,210	2,903 Added 6.18%	49,865 $4.04 Million
Q3 2023 Oct 23, 2023	BUY	$73.94 - $80.67 $386,040 - $421,178	5,221 Added 12.51%	46,962 $3.52 Million
Q2 2023 Jul 13, 2023	BUY	$76.01 - $86.7 $349,874 - $399,080	4,603 Added 12.39%	41,741 $3.22 Million
Q1 2023 Apr 25, 2023	BUY	$77.31 - $88.08 $532,433 - $606,606	6,887 Added 22.77%	37,138 $3.08 Million

Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $219,241 - $314,755	3,518 Added 13.16%	30,251 $2.6 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $347,713 - $397,178	5,840 Added 27.95%	26,733 $1.65 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $286,175 - $322,319	4,958 Added 31.11%	20,893 $1.29 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $208,106 - $260,779	3,593 Added 29.11%	15,935 $947,000
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $398,752 - $452,591	6,146 Added 99.19%	12,342 $896,000
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $123,263 - $132,987	1,821 Added 41.62%	6,196 $433,000
Q2 2021 Jul 22, 2021	BUY	$63.47 - $69.35 $50,649 - $55,341	798 Added 22.31%	4,375 $301,000
Q1 2021 May 18, 2021	BUY	$60.0 - $68.46 $214,620 - $244,881	3,577 New	3,577 $232,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tectonic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tectonic Advisors LLC with notifications on news.

Account

Tectonic Advisors LLC Gilead Sciences, Inc. Transaction History